The global medical imaging market, particularly MRI, is experiencing rapid growth driven by an aging population, increasing chronic disease prevalence, and demand for non-invasive diagnostics. This growth necessitates more sophisticated and reliable calibration tools like phantoms. Regulatory bodies are also pushing for higher standards in diagnostic accuracy and device performance. This technology offers a timely solution to meet these demands, enabling faster R&D cycles and more consistent quality control across the MRI ecosystem, crucial for maintaining competitive advantage and ensuring patient safety.
Enhances performance stability by 90% compared to conventional methods
Reduces manufacturing time by 70% through accelerated impregnation
Halves artifact generation risk, improving diagnostic reliability
This patent protects a specific manufacturing method for anisotropic MRI phantom components, centered on a combination of boiling and depressurization steps. It has demonstrated strong claim strength by overcoming examiner objections with precise amendments and arguments, establishing a robust and stable right against potential invalidation challenges.
This patent focuses on the manufacturing process for the phantom material. It does not cover novel MRI imaging sequences, advanced image processing algorithms, or the development of new non-wood-based phantom materials, offering white space for complementary IP development.
Reducing manufacturing time by 70% could save ~$50K/year (AI est.) in labor costs for producing 100 phantoms annually. A 50% reduction in artifact generation could avoid 200 re-examinations per year, saving ~$100K/year (AI est.) in re-examination and associated labor costs (at ~$530/instance). Total economic impact, including research efficiency and market gains, is estimated at over ~$200K/year (AI est.) per facility.
X: Manufacturing Efficiency
Y: Diagnostic Accuracy Contribution